2006-2009年

T. Kitamura, Y. Saitoh, N. Takashima, A. Murayama, Y. Niibori, H. Ageta, M. Sekiguchi, H. Sugiyama, K. Inokuchi. Adult neurogenesis modulates the hippocampus-dependent period of associative fear memory.Cell139(4), 814-827 (2009)[Pubmed]

Y. Oshima, N. Ouchi, M. Shimano, D.R. Pimentel, K.N. Papanicolaou, K.D. Panse, K. Tsuchida, E. Lara-Pezzi, S.-J. Lee, K. Walsh. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.Circulation120(16), 1606-1615 (2009)[Pubmed]

A. Uezumi, K. Tsuchida. Roles of mesenchymal progenitors, distinct from satellite cells, in Muscle Cell Physiology (edited by Y. Ohira). Osaka University Press pp109-119 (2009)

H. Ageta, S. Asai, Y. Sugiura, N. Goto-Inoue, N. Zaima, M. Setou. Layer-specific sulfatide localization in rat hippocampus middle molecular layer is revealed by nanoparticle-assisted laser desorption/ionization imaging mass spectrometry.Medical Molecular Morphology.42(1),16-23 (2009)[Pubmed]

K. Tsuchida, M. Nakatani, K. Hitachi, A. Uezumi, Y. Sunada, H. Ageta, K. Inokuchi. Activin signaling as an emerging target for therapeutic interventions.Cell Commun. Signal.7(1), 15 (2009)[Pubmed]

J. Miyawaki, S. Matsumura, R. Yuge, T. Murakami, S. Sato, A. Tomida, T. Tsuruo, T. Ichihashi, T. Fujinami, H. Irie, K. Tsuchida, S. Iijima, K. Shiba, M. Yudasaka.Biodistribution and ultrastructural localization of single-walled carbon nanohorns determined in vivo with embedded Gd2O3 labels.ACS nano3(6), 1399-1406 (2009)[Pubmed]

H. Gilson, O. Schakman, S. Kalista, P. Lause, K. Tsuchida, J. Thissen. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin.Am. J. Physiol. Endocrinol & Metabol.297, 157-164 (2009)[Pubmed]

A. S. D. Sandanayaka, O. Ito, M. Zhang, K. Ajima, S. Iijima, M. Yudasaka, T. Murakami, K. Tsuchida. Photoinduced electron transfer in Zinc phthalocyanine loaded on single-walled carbon nanohorns in aqueous solution.Advanced Materials21(43), 4366-4371 (2009)[Pubmed]

M. Asashima, Y. Ito, T. Chan, T. Michiue, M. Nakanishi, K. Suzuki, K. Hitachi, K. Okabayashi, A. Kondow, T. Ariizumi. In vitro organogenesis from undifferentiated cells in Xenopus.Developmental Dynamics238(6), 1309-1320 (2009)[Pubmed]

K. Hitachi, A. Kondow, H. Danno, Y. Nishimura, K. Okabayashi, M. Asashima. Molecular analyses of Xenopus laevis Mesp-related genes.Integrative Zoology. 4, 387-394 (2009)[Pubmed]

K. Hitachi, H. Danno, S. Tazumi, Y. Aihara, H. Uchiyama, K. Okabayashi, A. Kondow, M. Asashima. The Xenopus Bowline/Ripply family proteins negatively regulate the transcriptional activities of T-box transcription factors.Int. J. Dev. Biol.53: 631-639 (2009)[Pubmed]

M. Sekiguchi, F. Hayashi, K. Tsuchida, K. Inokuchi. Neuron type-selective effects of activin on development of the hippocampus.Neuroscience Letters452(3), 232-237 (2009)[Pubmed]

K. Jinno, T. Takahashi, K. Tsuchida, E. Tanaka, K. Moriyama. Acceleration of palate wound healing in Smad 3-deficient mice.J. Dental Res.88(8), 757- 761 (2009)[Pubmed]

K. Ajima, T. Murakami, Y. Mizoguchi, K. Tsuchida, T. Ichihashi, S. Iijima, M. Yudasaka. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.ACS Nano2(10), 2057-2064 (2008)[Pubmed]

K. Tsuchida, M. Nakatani, T. Murakami, A. Uezumi. Action of myostatin and its regulators in skeletal myogenesis. In Recent advances of skeletal muscle differentiation. (Editors : K. Tsuchida, S. Takeda)Research Signpost.pp109-126 (2008)[Pubmed]

K. Tsuchida. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.Acta Myologica14-18 (2008)[Pubmed]

Y. Ohsawa, T. Okada, A. Kuga, S. Hayashi, T. Murakami, K. Tsuchida, S. Noji, Y. Sunada. Caveolin-3 regulates myostatin signaling.Acta Myologica19-24 (2008)[Pubmed]

K. Tsuchida. Drug delivery systems for cancer treatment.Encyclopedia of Cancer2nd ed (Manfred Schweb Ed.) pp909-911 (2008)

M. Zhang, T. Murakami, K. Ajima, K. Tsuchida, A.S.D. Sandanayaka, O. Ito, S. Iijima, M. Yudasaka. Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy.Proc. Natl. Acad. Sci. U.S.A.105(39), 14773-14778 (2008) (Press release)[Pubmed]

T. Murakami, H. Sawada, G. Tamura, M. Yudasaka, S. Iijima, K. Tsuchida. Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.Nanomed.3(4), 453-63 (2008)[Pubmed]

K. Tsuchida. Targeting myostatin for therapies against muscle-wasting disorders.Curr. Opin. Drug Discov. Devel.11(4), 487-494 (2008)[Pubmed]

H. Ageta, A. Murayama, R. Migishima, S. Kida, K. Tsuchida, M. Yokoyama, K. Inokuchi. Activin in the brain modulates anxiety-related behavior and adult neurogenesis.PLos ONEe1869 (2008)[Pubmed]

K. Tsuchida, M. Nakatani, A. Uezumi, T. Murakami and X. Cui. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.Endocrine J.55(1), 11-21 (2008)[Pubmed]

A. Kurisaki, I. Inoue, K. Kurisaki, N. Yamakawa, K. Tsuchida, H. Sugino. Activin induces long-lasting N-methyl-d-aspartate receptor activation via scaffolding PDZ protein activin receptor interacting protein 1.Neuroscience151(4), 1225-1235 (2008)[Pubmed]

T. Murakami and K. Tsuchida. Recent advances in inorganic nanoparticle-based drug delivery systems.Mini. Rev. Med. Chem.8(2), 175-183 (2008)[Pubmed]

M. Nakatani, Y. Takehara, H. Sugino, M. Matsumoto, O. Hashimoto, Y. Hasegawa, T. Murakami, A. Uezumi, S. Takeda, S. Noji, Y. Sunada, and K. Tsuchida. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.FASEB J.22(2), 477-487 (2008)[Pubmed]

H. Ogino, S. Yano, S. Kakiuchi, H. Muguruma, K. Ikuta, H. Uehara, K. Tsuchida, H. Sugino and S. Sone. Follistatin Suppresses the Production of Experimental Multiple-organ Metastasis by Small Cell Lung Cancer Cells in NK cell-Depleted SCID Mice.Clin. Cancer Res.14(3), 660-667 (2008)[Pubmed]

Y. Shoji-Kasai, H. Ageta, Y. Hasegawa, K. Tsuchida, H. Sugino, K. Inokuchi. Activin, a member of the TGF-β superfamily, increases the number of synaptic contacts and the length of dendritic spine necks by modulating spinal actin dynamics.J. Cell Sci.120(21), 3830-3837 (2007)[Pubmed]

Y. Takehara-Kasamatsu, K. Tsuchida, M. Nakatani, T. Murakami, A. Kurisaki, O. Hashimoto, H. Ohuchi, H. Kurose, K. Mori, S. Kagami, S. Noji, H. Sugino. Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development.J. Med. Invest.54(3-4), 276-288 (2007)[Pubmed]

K. Pryor-Koishi, H. Nishizawa, T. Kato, H. Kogo, T. Murakami, K. Tsuchida, H. Kurahashi, Y. Udagawa. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia.Brit. J. Obst. Gynaecol.114(9), 1128-1137 (2007)[Pubmed]

Y. Morine, K. Tsuchida, H. Sugino, K. Takamura, S. Tashiro, M. Shimada. Effects of preactivation by portal vein ligation on liver regeneration following massive hepatectomy in rats.Hepatogastroenterology54(76), 1216-1221 (2007)[Pubmed]

H. Sawada, H. Ishiguro, K. Nishii, K. Yamada, K. Tsuchida, H. Takahashi, J. Goto, I. Kanazawa, T. Nagatsu. Characterization of neuron-specific huntingtin aggregates in human huntingtin knock-in mice.Neurosci. Res.57(4), 559-573 (2007)[Pubmed]

K. Miyake, K. Tsuchida, H. Sugino, S. Imura, Y. Morine, M. Fujii, M. Shimada. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.Cancer Chemother. Pharmacol.59(1), 113-126 (2007)[Pubmed]

S. Fukada, A. Uezumi, M. Ikemoto, S. Masuda, M. Segawa, N. Tanimura, H. Yamamoto, Y. Miyagoe-Suzuki, S. Takeda. Molecular signature of quiescent satellite cells in adult skeletal muscle.Stem Cells25, 2448-2459 (2007)[Pubmed]

M. Ikemoto, S. Fukada, A. Uezumi, S. Masuda, H. Miyoshi, H. Yamamoto, M.R. Wada, N. Masubuchi, Y. Miyagoe-Suzuki, S. Takeda. Autologous transplantation of SM/C-2.6+ satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice.Mol. Ther.15:2178-2185 (2007)[Pubmed]

Y. Ohsawa, H. Hagiwara, M. Nakatani, A. Yasue, K. Moriyama, T. Murakami, K. Tsuchida, S. Noji, Y. Sunada. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.J. Clin. Invest.116(11), 2924-2934 (2006)[Pubmed]

K. Tsuchida, Y. Sunada, S. Noji, T. Murakami, A. Uezumi, M. Nakatani. Inhibitors of the TGF-beta superfamily and their clinical applications.Mini. Rev. Med. Chem.6(11), 1255-61 (2006)[Pubmed]

M. Kogame, S. Matsuo, M. Nakatani, A. Kurisaki, H. Nishitani, K. Tsuchida, H. Sugino. ALK7 is a novel marker for adipocyte differentiation.J. Med. Invest.53(3-4), 238-245 (2006)[Pubmed]

M. Funaba, K. Nakaya, T. Ikeda, M. Murakami, K. Tsuchida, H. Sugino. Requirement of Smad3 for mast cell growth.Cell. Immunol.240(1), 47-52 (2006)[Pubmed]

Z.H. Liu, K. Tsuchida, T. Matsuzaki, Y.L. Bao, A. Kurisaki, H. Sugino. Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.J. Endocrinol.189(2), 409-421 (2006)[Pubmed]

K.Y. Arai, K. Tsuchida, C.M. Li, G. Watanabe, H. Sugino, K. Taya, T. Nishiyama. Purification of recombinant activin A using the second follistatin domain of follistatin-related gene (FLRG).Protein Expr. Purif.49(1), 78-82 (2006) [Pubmed]

K. Tsuchida. The role of myostatin and bone morphogenetic proteins in muscular disorders.Expert Opin Biol Ther.6(2), 147-54.(2006)[Pubmed]

M. Funaba, K. Nakaya, T. Ikeda, M. Murakami, K. Tsuchida, H. Sugino. Requirement of Smad3 for mast cell growth.Cell Immunol.240(1), 47-52. (2006)[Pubmed]

M. Funaba, T. Ikeda, M. Murakami, K. Ogawa, Y. Nishino, K. Tsuchida, H. Sugino, M. Abe. Involvement of p38 MAP kinase and Smad3 in TGF-beta-mediated mast cell functions.Cell Signal.18(12), 2154-61. (2006)[Pubmed]

M. Funaba, T. Ikeda, M. Murakami, K. Ogawa, Y. Nishino, K. Tsuchida, H. Sugino, M. Abe. Transcriptional regulation of mouse mast cell protease-7 by TGF-beta.Biochim. Biophys. Acta.1759(3-4), 166-70. (2006)[Pubmed]

2008- 2022 藤田医科大学 総合医科学研究所 難病治療学研究部門 All Right Reserved.